BMEA
Price
$1.28
Change
-$0.01 (-0.78%)
Updated
Jul 15, 04:10 PM (EDT)
Capitalization
92.9M
19 days until earnings call
Intraday BUY SELL Signals
CAI
Price
$17.22
Change
+$0.27 (+1.59%)
Updated
Jul 15, 04:13 PM (EDT)
Capitalization
4.79B
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BMEA vs CAI

BMEA vs CAI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BMEA vs. CAI commentary
Jul 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and CAI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 15, 2026
Stock price -- (BMEA: $1.29 vs. CAI: $16.95)
Brand notoriety: BMEA and CAI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 46% vs. CAI: 75%
Market capitalization -- BMEA: $92.9M vs. CAI: $4.79B
BMEA [@Biotechnology] is valued at $92.9M. CAI’s [@Biotechnology] market capitalization is $4.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $120.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileCAI’s FA Score has 1 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • CAI’s FA Score: 1 green, 4 red.
According to our system of comparison, BMEA is a better buy in the long-term than CAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 4 TA indicator(s) are bullish while CAI’s TA Score has 4 bullish TA indicator(s).

  • BMEA’s TA Score: 4 bullish, 6 bearish.
  • CAI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CAI is a better buy in the short-term than BMEA.

Price Growth

BMEA (@Biotechnology) experienced а -7.86% price change this week, while CAI (@Biotechnology) price change was -2.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.30%. For the same industry, the average monthly price growth was +7.05%, and the average quarterly price growth was +1917.99%.

Reported Earning Dates

BMEA is expected to report earnings on Aug 03, 2026.

CAI is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (-3.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAI($4.79B) has a higher market cap than BMEA($92.9M). BMEA YTD gains are higher at: 4.032 vs. CAI (-37.176). CAI has higher annual earnings (EBITDA): 111M vs. BMEA (-63.38M). CAI has more cash in the bank: 823M vs. BMEA (44.7M). BMEA has less debt than CAI: BMEA (1.24M) vs CAI (431M). CAI has higher revenues than BMEA: CAI (907M) vs BMEA (0).
BMEACAIBMEA / CAI
Capitalization92.9M4.79B2%
EBITDA-63.38M111M-57%
Gain YTD4.032-37.176-11%
P/E RatioN/AN/A-
Revenue0907M-
Total Cash44.7M823M5%
Total Debt1.24M431M0%
FUNDAMENTALS RATINGS
CAI: Fundamental Ratings
CAI
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
55

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEACAI
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 21 days ago
53%
Declines
ODDS (%)
N/A
Bearish Trend 29 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
29%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
13%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signal:
Gain/Loss:
CAI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMD10.720.09
+0.85%
Western Asset Emerging Markets Debt Fund
IYLD22.120.07
+0.32%
iShares Morningstar Multi-Asset Inc ETF
ISHP32.81N/A
N/A
First Trust S-Network Glb E-Com ETF
DVIN30.31N/A
N/A
WEBs Industrials XLI Defined Vol ETF
IWN219.60-0.18
-0.08%
iShares Russell 2000 Value ETF

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been loosely correlated with CLRB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BMEA jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
-3.01%
CLRB - BMEA
39%
Loosely correlated
N/A
ACET - BMEA
39%
Loosely correlated
+3.27%
CAI - BMEA
38%
Loosely correlated
-0.64%
HUMA - BMEA
36%
Loosely correlated
+2.31%
MLTX - BMEA
36%
Loosely correlated
-4.36%
More

CAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAI has been loosely correlated with BMEA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CAI jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAI
1D Price
Change %
CAI100%
-0.64%
BMEA - CAI
38%
Loosely correlated
-3.01%
TECH - CAI
38%
Loosely correlated
-0.18%
RXRX - CAI
29%
Poorly correlated
+1.21%
VTGN - CAI
29%
Poorly correlated
-2.61%
HRMY - CAI
28%
Poorly correlated
-2.05%
More